Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (109 ops.)
Latest filing published 21 Oct 2026 for Disc Medicine, Inc., €19k.
Filing timeline
BuySaleKevin Bitterman
Insider track record
Disclosed buys
2
Disclosed sells
109
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +17.0%Entry US$44.18 · Close at T+365 US$51.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin Bitterman: trading record in brief
Kevin Bitterman sits as a Director at 3 Nasdaq-listed companies: Disc Medicine, Inc. (35 filings), Editas Medicine, Inc. (14) and Akero Therapeutics, Inc. (5). The record of 54 filings is heavy in amounts: 44 sales worth EUR 53.7 million, with a median of EUR 404,691, against 2 purchases worth EUR 11.2 million.
The largest sales are May 22, 2017 (EUR 15,126,089) and September 8, 2016 (EUR 7,452,480), both at Editas, then January 23, 2024 (EUR 5,129,612) at Disc Medicine. The two purchases date from June 17, 2024 (EUR 7,448,346, Disc Medicine) and June 24, 2019 (EUR 3,789,375, Akero); they are 4% of the market trades.
Activity intensifies: 13 filings in 2016, then 10 in 2025 and 19 in 2026. The last twelve months count 21 filings, 18 of them sales. They appear a median of 2 days after the trade.
Bitterman's own market trades within 30 days of colleagues at Disc Medicine, Inc. number 19, 16 and 15, all on the same side. Names in order: John D. Quisel, Jonathan Yen-Wen Yu and Rahul Khara.
Companies and markets linked to Kevin Bitterman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations92 total
266 shares@ US$80.230.0007% mcap0.1% of flowCommon StockSEC:0001591747-26-000009:8
5,937 shares@ US$79.970.016% mcap1.2% of flowCommon StockSEC:0001591747-26-000009:0
4,942 shares@ US$79.970.013% mcap1.0% of flowCommon StockSEC:0001591747-26-000009:1
2,869 shares@ US$79.950.0076% mcap0.6% of flowCommon StockSEC:0001591747-26-000009:3
2,388 shares@ US$79.950.0063% mcap0.5% of flowCommon StockSEC:0001591747-26-000009:4
11,470 shares@ US$80.230.031% mcap2.2% of flowCommon StockSEC:0001591747-26-000009:7
115 shares@ US$79.970.0003% mcap0.0% of flowCommon StockSEC:0001591747-26-000009:2
55 shares@ US$79.950.0001% mcap0.0% of flowCommon StockSEC:0001591747-26-000009:5
13,783 shares@ US$80.230.037% mcap2.7% of flowCommon StockSEC:0001591747-26-000009:6
7,136 shares@ US$45.690.010% mcap0.8% of flowCommon StockSEC:0001591747-26-000007:0
10,000 shares@ US$38.850.012% mcap1.0% of flowCommon StockSEC:0001591747-26-000007:1
10,000 shares@ US$50.860.016% mcap1.3% of flowCommon StockSEC:0001591747-26-000007:2
27,136 shares@ US$70.110.061% mcap4.9% of flowCommon StockSEC:0001591747-26-000007:3
912 shares@ US$79.960.0023% mcap0.1% of flowCommon StockSEC:0001591747-26-000005:0
759 shares@ US$79.960.0019% mcap0.1% of flowCommon StockSEC:0001591747-26-000005:1
18 shares@ US$79.960.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000005:2
70 shares@ US$79.950.0002% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:0
58 shares@ US$79.950.0002% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:1
1 shares@ US$79.950.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:2
26,542 shares@ US$80.170.082% mcap5.5% of flowCommon StockSEC:0001591747-26-000002:3
22,090 shares@ US$80.170.069% mcap4.6% of flowCommon StockSEC:0001591747-26-000002:4
511 shares@ US$80.170.0016% mcap0.1% of flowCommon StockSEC:0001591747-26-000002:5
10 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:6
9 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:7
2 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:8
25 of 92 declarations
